Related by context. All words. (Click for frequent words.) 73 mcg mL 70 ug ml 68 μg ml 68 MIC# [001] 67 microg 67 μmol L 66 lopinavir r arm 66 mU liter 65 nM 65 adverse reactions incidence 65 μg mL 65 leukocyte count 65 uM 65 imipenem 65 ug mL 65 mIU ml 65 F irritability drowsiness 65 oral allopurinol 64 daunorubicin 64 aspartate aminotransferase 64 mmol l 64 clodronate 64 % Confidence Interval 64 gastric pH 64 ug kg 64 Å -1 63 cells uL 63 log# copies mL 63 X ULN 63 fosamprenavir 63 microgram kg 63 ALT elevation 63 oxycodone CR 63 log# reduction 63 mU L 63 adjunctive placebo 63 degrees C/#.# degrees 63 mcg kg min 63 SGPT 62 micromolar 62 indinavir 62 mEq L 62 lumbar spine BMD 62 alanine aminotransferase ALT 62 biologic DMARD 62 adverse reactions occurring 62 alanine aminotransferase 62 inhibitory concentration 62 mg kg -1 62 x ULN 62 rFSH 62 creatinine ratio 62 lopinavir r 62 ertapenem 62 tacrolimus ointment 61 nmol liter 61 Efficiency ratio taxable 61 HbA 1c levels 61 μg kg 61 hemagglutination inhibition 61 μg L 61 causality incidence 61 ritonavir boosted atazanavir 61 titrated glipizide 61 5-FU/LV 61 neutrophil counts 61 Peg IFN 61 pmol L 61 % miconazole nitrate 61 IFN α 61 interleukin IL -6 61 hematologic toxicity 61 baseline HbA1c 61 % CI #.#-#.# [003] 61 p = NS 61 Interferon alfa 61 receiving VICTRELIS 61 #OHD 61 ng dL 61 pg g 61 #.#mg/dL 61 ECOG PS 61 hemoglobin Hb 61 symptomatic intracranial hemorrhage 61 fluticasone salmeterol 61 virologic failures 60 pg mL 60 REYATAZ r arm 60 dizziness nausea diarrhea 60 #.#-#.# [011] 60 abdominal pain flatulence 60 mg/m2/day 60 μg dL 60 p = ns 60 ug g 60 mg eq 60 tipranavir r 60 #ng/ml 60 mCi kg 60 microbiological eradication 60 mcg QD 60 picomolar 60 interleukin IL 60 mcg dL 60 μg dose 60 μg liter 60 -#.# log# copies mL 60 mIU L 60 nmol 60 Tangible Assets Ratio 60 lymphocyte count 60 Ishak fibrosis score 60 pmol 60 μM 60 lispro 60 umol L 60 ALT flares 60 4mg/kg 60 statin monotherapy 60 MBq 60 mcg Albuferon 60 ceftazidime 60 plasma folate 60 mol L 60 pyrazinamide 60 transaminase elevations greater 60 amprenavir 60 mg/# hours 60 normal ULN 60 HT 1A 60 #mg/kg [001] 60 sUA 60 hours postdose 60 serum IGF 60 nmol L. 60 mso footer margin 60 seroprotective 60 plus aztreonam 60 CLA isomers 60 serum creatinine levels 60 low dose Iluvien 60 HAI titers 60 HBeAg seroconversion 60 TMC# r 59 comparator arm 59 mIU mL 59 HI titers 59 infliximab monotherapy 59 piperacillin tazobactam 59 mg ml 59 IU ml 59 8mg/kg 59 LS BMD 59 permanently discontinue Vectibix 59 heterozygotes 59 pT3 59 bioavailable testosterone 59 certolizumab 59 μg d 59 mg kg dose 59 mcg ml 59 mcg albinterferon alfa 2b 59 timolol 59 HPV-#/# 59 baseline Hb 59 placebo dexamethasone 59 seroprotection 59 relapsed MM 59 DAS# remission 59 cytokeratin 59 Streptococcus pyogenes 59 hemoglobin A1c HbA1c 59 PREZISTA r arm 59 mmHg diastolic 59 tPSA 59 miconazole nitrate 59 CIMZIA TM 59 plasminogen activator inhibitor 59 flutamide 59 oxycodone IR 59 FluCAM 59 mu g 59 hypophosphatemia 59 transaminase elevations 59 LUMIGAN ® 59 ULORIC 59 μg l 59 apolipoprotein B 59 mg Androxal 59 -#.# log# 59 corticosteroid dose 59 Cholinesterase Inhibitors 59 â ‰ ¥ 59 mcg BID 59 salmeterol fluticasone propionate 59 nmol l 59 serum cortisol 59 CsA 59 mL/min/#.# m 2 59 biochemical relapse 59 pg ml 59 nadolol 59 oral levofloxacin 59 isoproterenol 59 mmol kg 59 μg dl 59 ARB telmisartan 59 mg TID 59 glulisine 59 BUPHENYL 59 SUVmax 59 nanomolar 59 serum prostate 59 serum urate 59 isoenzyme 59 mg/# h 59 emtricitabine tenofovir 58 SGOT 58 serum testosterone 58 PSA nadir 58 steroid dexamethasone 58 pegylated IFN 58 -#.# mg dL [002] 58 AZT zidovudine Retrovir 58 metformin monotherapy 58 dexamethasone Decadron 58 mg Proellex 58 LEXIVA r 58 serum urate levels 58 somnolence headache 58 serum concentrations 58 mCi m 2 58 prilocaine 58 EDSS score 58 #mmHg [001] 58 mg m² 58 g cm 58 K#N 58 leukopenia 58 imiquimod cream 58 binary restenosis 58 α tocopherol 58 plasma leptin 58 CDAI score 58 PREZISTA ritonavir 58 IOP lowering 58 pmol liter 58 REMICADE monotherapy 58 octreotide LAR 58 mEq 58 efavirenz emtricitabine 58 HBeAg positive 58 dapagliflozin plus 58 CK # plasma concentrations 58 triacylglycerol 58 confidence interval #.#-#.# 58 doripenem 58 antibody titers 58 Adefovir 58 benazepril 58 mm Hg systolic 58 P ≤ 58 micromoles 58 achieved ACR# 58 posaconazole 58 complete cytogenetic response 58 FTE staffing 58 Index CDAI 58 Stent p = 58 balsalazide 58 trimethoprim 58 mg kg ip 58 dose dabigatran 58 luminal diameter 58 Hazard Ratio 58 diuretic chlorthalidone 58 nmol L 58 recurrent VTE 58 antibody titer 58 S. aureus isolates 58 #mg #mg #mg [003] 58 SmartGrowth Deposits 58 HBsAg 58 milliliter ng ml 58 vaccine serotypes 58 Acetate Rectal Suppositories 58 log# 58 NPH insulin 58 #mg doses [002] 58 generalized edema 58 serum PTH 58 + PH# 58 plasma creatinine 58 ® fluocinonide Cream 58 HBeAg negative patients 58 CI -#.# 58 azacytidine 58 Noninterest expense totaled 58 cis retinoic acid 58 plus dexamethasone 58 baseline LDH 58 mM 58 fasting plasma glucose FPG 58 adjunctive ABILIFY 58 MADRS score 58 micafungin 58 Operative mortality 58 inactivated poliovirus vaccine 58 Engerix B 58 #Gy 57 NEUPOGEN R 57 abacavir lamivudine 57 CR nPR 57 serum phosphorus 57 plus methotrexate 57 mg simvastatin 57 -#.# ± [002] 57 Mg Uk 57 Serum creatinine 57 mg/# mg [002] 57 ng dl 57 3mg/kg 57 Soriatane R 57 microvessel density 57 doxazosin 57 % CI #.#-#.# [007] 57 #mg/day [002] 57 intramuscularly 57 NovoLog ® Mix 57 doxorubicin cyclophosphamide 57 Scale EDSS score 57 HCV replicon 57 Chandra Sturrup Bahamas 57 KRAS mutations occur 57 urine albumin 57 generation cephalosporins 57 PaO 2 57 urinary excretion 57 Soriatane R acitretin capsules 57 TEAEs 57 statistical significance p 57 hydroxyvitamin D levels 57 budesonide pMDI 57 Decitabine 57 weekly CSBMs 57 elevated ALT 57 International NASDAQ HSII 57 mg XP# 57 ritonavir boosted 57 invasive ductal 57 prednisone prednisolone 57 glycated hemoglobin levels 57 idraparinux 57 advanced adenomas 57 neuropathy sensory 57 airway hyper responsiveness 57 grade cervical intraepithelial 57 plasma fibrinogen 57 serum homocysteine 57 QTcF 57 μg g 57 serum LDL cholesterol 57 lumbar spine bone 57 Peginterferon Alfa 2a 57 FHLB borrowings decreased 57 kBq kg 57 Omiganan 57 ml min 57 ketorolac 57 seropositivity 57 immunoglobulin G 57 sitosterol 57 adiponectin concentrations 57 evaluable subjects 57 isoprostane 57 CD# + [001] 57 INCOME TAX EFFECTS 57 atheroma volume 57 systemic absorption 57 Available Seat Kilometres ASKs 57 #.#mg/kg [002] 57 #μg [001] 57 Nilotinib 57 albumin excretion rate 57 plasma glucose concentration 57 ceftriaxone 57 FOLFOX4 57 salmeterol fluticasone 57 m@#.# g t Au [003] 57 fluorescence intensity 57 mg hydrochlorothiazide 57 lopinavir 57 EDSS scores 57 PROCTOCORT ® Suppository Hydrocortisone 57 mg qd 57 Biaxin clarithromycin 57 tenofovir emtricitabine 57 elevated LDH 57 Evoclin R 57 dose cytarabine 57 chloride secretion 57 Aptivus ® 57 HBeAg 57 angiographic restenosis 57 hip BMD 57 #mg/kg [002] 57 FluCAM arm 57 #.#g/day 57 CIMZIA ™ 57 liver histology 57 Noninterest Expense Noninterest expense 57 postdose 57 mg BID 57 fluorouracil leucovorin 57 dose dependently 57 colorectal carcinomas 57 Pegasys peginterferon alfa 2a 57 Churn Rate 57 expressors 57 serum sodium concentration 57 serum estradiol 57 serum lipid levels 57 mucosal inflammation 57 IRLS score 57 cefotaxime 57 IFN beta 57 IELT 57 Knodell necroinflammatory score 57 severe neutropenia 57 BMPR2 57 Endologix NASDAQ ELGX 57 mg/m2 dose 57 IGFBP 57 Enterococcus faecium 57 亿元 57 mg BID dose 57 interferon alfa 57 left ventricular systolic 56 ritonavir boosted lopinavir 56 intracranial hemorrhage ICH 56 LANTUS R 56 antiandrogen 56 calculated creatinine clearance 56 BARACLUDE ® 56 baseline A1C 56 #.#/#.# mmHg [001] 56 telaprevir dosed 56 thyrotropin levels 56 systemic bioavailability 56 neutropaenia 56 fin div 56 % TECHNICAL UPTREND 56 saline placebo 56 partial remissions 56 colorectal carcinoma 56 mL/min/#.# m2 56 hypogonadal 56 cm -3 56 troponin T 56 ara C 56 r2 = 56 g dl 56 vulvar vaginal 56 amoxicillin clavulanate 56 adverse reactions irrespective 56 p = #.# [003] 56 p = .# [001] 56 cfu 56 baseline serum creatinine 56 oxacillin 56 fluconazole resistant 56 mL sec 56 dose ritonavir 56 mm Hg diastolic 56 APTIVUS r 56 receiving ISENTRESS 56 Flu Cy 56 IV Therapies 56 IU mL 56 serum phosphate 56 cm ^ sup 56 mg tid 56 transaminases 56 Prepaid churn 56 advanced adenoma 56 norethindrone 56 mesalamine granules 56 glucuronide 56 PegIFN RBV 56 locoregional recurrence 56 ug L 56 Zometa hazard 56 rectal tenesmus 56 eosinophil count 56 inhaled fluticasone 56 % asthenia malaise 56 MCyR 56 AOR = 56 intramuscular dose 56 TREO + Y#O# 56 - -Books Market Segmentation 56 HDRS 56 tsp vanilla extract 56 oral hypoglycemic agent 56 pegylated interferon alpha 56 Pred Forte 56 TIMP 56 TransIntl.com #MB PC 56 oxcarbazepine 56 jana.mlcochova @ thomson.com 56 Eur Arch 56 mmol L. 56 CFU g 56 severe rotavirus gastroenteritis 56 polymyxin B 56 mg/#.# mg [002] 56 renal cell carcinomas 56 laboratory abnormalities 56 trimethoprim sulfamethoxazole 56 zidovudine lamivudine 56 8 OHdG 56 Prograf ® 56 noninterest expense totaled 56 cGy 56 TT genotype 56 bFGF 56 nadroparin 56 % CI #.#-#.# [004] 56 log# IU mL 56 mcg linaclotide 56 aminotransferase elevations greater 56 aminotransferase levels 56 CCyR 56 fumarate 56 J Am Soc 56 GDAXI indexes 56 timepoints 56 insulin glulisine 56 scores TNSS 56 serum folate 56 biphasic insulin aspart 56 Cream USP 1 56 serum TSH 56 g dietary fiber 56 triiodothyronine 56 boosted atazanavir 56 morphometric vertebral fractures 56 Stomatitis 56 placebo p 56 interferon alfa 2a 56 alpha2 56 thyrotropin 56 candidemia 56 QbG# 56 HBV DNA 56 femoral neck BMD 56 arterial thromboembolic events 56 Del Worsham Solara 56 Blended ARPU 56 anaplastic astrocytomas 56 iPTH 56 low dose ritonavir 56 oral ribavirin 56 white petrolatum Ointment 56 HGPIN 56 response CCyR 56 mg orally 56 PASI scores 56 IGFBP 3 56 Y#O# 56 cellularity 56 unfractionated heparin UFH 56 Nonperforming loans totaled 56 aspartate aminotransferase AST 56 baseline neutrophil counts 56 Platelet counts 56 injected subcutaneously 56 pegIFN 56 HbF 56 kDa 56 Lupuzor ™ 56 & s2 = 56 #.#mL 56 antiandrogens 56 COMBIVIR 56 + #.#mm 56 Mg Usa 56 q#h 56 nondiabetic patients 56 iodixanol 56 statistically significant p = 56 gemcitabine cisplatin 56 CIN2 56 mmHg systolic 56 μS cm 55 Fasting blood glucose 55 HbA1C 55 mu m 55 6mg 55 P. aeruginosa 55 Prepaid ARPU 55 protein excretion 55 Ryan Schnitz Buell 55 calcipotriene 55 chlorthalidone 55 MMSE scores 55 Interferon beta 1b 55 H#K#me# 55 histologic subtype 55 IFN gamma 55 serum uric acid 55 μmol 55 interferon IFN 55 viral titers 55 mg QD 55 ALVESCO 55 ppm boron 55 IFN alfa 55 tertiles 55 pCR 55 Viread Emtriva 55 elevated serum creatinine 55 TPV r 55 colorectal adenoma 55 K#R [002] 55 Peginterferon 55 Neisseria gonorrhoeae 55 tirofiban 55 peginterferon alfa 2b 55 viewers #.#mil 55 HCV genotypes 55 mcg dose 55 clobetasol propionate Foam 55 Parathyroid Hormone 55 REYATAZ ritonavir 55 cells μL 55 #mg/m# [001] 55 PBMCs 55 CDAI 55 IgG1 55 dimeglumine 55 tapentadol ER 55 seroconverted 55 inhibitory concentrations 55 serum HBV DNA 55 peginterferon alfa 2a 55 yttrium oxide 55 Cmax 55 sulfasalazine 55 Q2W 55 titres 55 #-#,# mg 55 retapamulin 55 #mg dose [002] 55 lymphocyte counts 55 parous women 55 Suppository Hydrocortisone Acetate Rectal 55 IBDQ 55 ® emtricitabine 55 myalgia arthralgia 55 Obes Res 55 efavirenz EFV 55 lanthanum carbonate 55 MARRIOTT REVENUES totaled 55 SCIg 55 HER2 expression 55 % #NY.INST 55 elevated triglyceride levels 55 piotr.skolimowski @ thomson.com 55 pyrexia mucositis sepsis febrile 55 Non inferiority 55 Nonaccrual loans totaled 55 ß = 55 carcinoembryonic antigen 55 Noninterest expense decreased 55 bronchoalveolar lavage 55 NRTI resistance 55 homocysteine concentrations 55 UGT#A# * 55 Hycamtin ® 55 ml kg 55 Elitek 55 serum sodium 55 LB# [003] 55 PEGylated anti 55 tolterodine ER 55 prolactin levels 55 immunoreactivity 55 baseline FEV 55 Vancocin p = 55 hepatic insulin sensitivity 55 Hb A1c 55 HOMA IR 55 #mg q8h 55 dopamine partial agonist 55 Pegasys ® 55 mcg kg REBETOL 55 dysuria 55 NNRTI resistance 55 fluticasone propionate 55 Sensipar R 55 tertile 55 neutrophil count 55 #mg BID [003] 55 adefovir 55 dosing cohort 55 CC genotype 55 immunostaining 55 mainline passenger RASM 55 serum aminotransferase levels 55 angiotensin converting enzyme inhibitors 55 microliters 55 Leydig cell 55 pegylated liposomal doxorubicin 55 BBB Baa BB 55 TTM Technologies NASDAQ TTMI 55 ergocalciferol 55 levofloxacin 55 TNF alpha IL 55 interferon α 55 abdominal distention 55 insulin lispro 55 IIIa inhibitors 55 Fully diluted EPS 55 hematological parameters 55 #.#/#.# mm Hg [003] 55 TIMP 1 55 glycated hemoglobin HbA1c 55 kg/m3 55 transdermal estradiol 55 Gary Scelzi Dodge Stratus 55 Pro forma EPS 55 norgestimate 55 rizatriptan 55 anemia hemoglobin 55 confidence interval CI 55 ADPKD 55 Fig. 3b 55 undetectable HBV DNA 55 tHcy 55 amphotericin B 55 BOEd 55 MILLION SHARES 55 intravenous bolus injection 55 hepatocellular carcinomas 55 TOTAL FG % 55 hypokalemia 55 Doxil ® 55 Nonresidential structures 55 beclomethasone dipropionate 55 nevirapine Viramune 55 aminotransferases 55 neutropenia dehydration dyspnea 55 nausea dehydration dyspnea 55 medroxyprogesterone acetate 55 lactate dehydrogenase 55 CI #.#-#.# [001] 55 ARCOXIA 55 plus prednisone prednisolone 55 P = .# 55 FOLFOX4 alone 55 urinary calcium excretion 55 ropivacaine 55 EBITDA1 55 TSE# closed 55 tiotropium bromide 55 Conceptus NASDAQ CPTS 55 serum calcium 55 Leasable area 55 sulfonamide 55 insulin detemir 55 microlitre 55 atorvastatin #mg 55 subcutaneously injected 55 μg 55 plus medroxyprogesterone acetate 55 ALT elevations 55 CFU ml 55 pCi l 55 TAB Double 55 postintervention 55 tigecycline 55 placebo PBO 55 lamivudine refractory patients 55 % CI #.#-#.# [006] 55 AAA Aaa AAA 55 ethambutol 55 evaluating tivozanib 55 lamivudine monotherapy 55 lymphopenia 55 Viread Emtriva Sustiva 55 serum triglyceride 55 cephalosporin antibiotics 55 #ug [002] 55 Palonosetron 55 EGYPTIAN POUND 55 thrombosis embolism 55 HIV uninfected 55 HbA1C levels 55 chlorambucil 55 GSTP1 55 AM EDT POSITION 55 hypopneas 55 TOTAL FG 55 per deciliter mg 55 mcg kg 55 Homocysteine levels 55 DOXIL 55 BMS p = 55 oral vancomycin 55 terfenadine 55 definite stent thrombosis 55 Metab Disord 55 NBV margin 55 osteosarcomas 55 g carbo 55 GABHS 55 mso header 55 interferon alfa 2b 55 - -winger Colby Armstrong 55 g trans fats 54 p ≤ 54 Bifidobacterium lactis 54 AVAILABLE SEAT KM 54 χ 54 clinically evaluable patients 54 microgram doses 54 amikacin 54 Hgb 54 Womacks Adjusted EBITDA 54 CD3 + 54 CK # plasma 54 FFNS 54 nelfinavir 54 postmenopausal osteoporotic women 54 alteplase 54 Ondansetron Injection USP 54 NY ESO 54 W mK 54 topical gel formulation 54 dose cohort 54 achieved mucosal healing 54 ìg 54 quetiapine risperidone 54 Benzoyl Peroxide 54 mg kg hr 54 CANCIDAS 54 hyperphenylalaninemia HPA due 54 Crohn Disease Activity 54 Thrombin 54 kGy 54 CIN3 54 FHLB advances decreased 54 Tony Pedregon Impala 54 bactericidal activity 54 #mg capsules [001] 54 inhibitory antibodies 54 anti HBs 54 serum calcium levels 54 mg ustekinumab 54 parasitaemia 54 = .# 54 dalteparin 54 adriamycin 54 Thal Dex 54 Cuban Peso CUP 54 achieved statistical significance 54 deoxy 54 mutated KRAS 54 MMSE score 54 urate lowering therapy 54 #mg BID [001] 54 Hazard Ratio HR 54 Nephrol 54 HbA 1c 54 Nettoergebnis um 54 mg d 54 TMP SMX 54 PEG IFN 54 linoleic acid LA 54 inhibitor RG# 54 prednisone prednisolone plus 54 BUPHENYL R sodium phenylbutyrate 54 mcg doses 54 kg m² 54 homozygotes 54 Sees FY# revs 54 Kidney Int 54 mean baseline HbA1c 54 consolidated passenger RASM 54 plasma triglycerides 54 neoplasias 54 LPV r 54 deferoxamine 54 AVODART 54 Fluticasone 54 mGy 54 highly emetogenic 54 dihydrochloride 54 candesartan cilexetil 54 m 54 MeV 54 ohm cm 54 pegylated interferon alfa 54 HBeAg negative 54 AUC0 54 idarubicin 54 osmolality 54 cEVR 54 Lovaza ® 54 concentration Cmax 54 mg + GLY 54 follicular phase 54 nanograms milliliter 54 brand ciclesonide HFA 54 g l 54 intima media thickness 54 delivered subcutaneously 54 Hb A1C 54 creatine phosphokinase 54 MLN EUROS 54 detemir 54 pegylated interferon alfa 2a 54 NOAEL 54 VANOS TM fluocinonide Cream 54 tipranavir ritonavir 54 min -1 54 protease inhibitors PIs 54 VELCADE melphalan 54 dehydroepiandrosterone sulfate 54 Index CDAI score 54 Million ozs 54 oxyhemoglobin 54 mmol 54 undetectable viral 54 micrograms mcg 54 Folfox 54 PegIFN 54 cyclophosphamide methotrexate 54 hepatic enzymes 54 μmol l 54 betamethasone 54 abacavir Ziagen 54 adrenocorticotropic hormone ACTH 54 tamsulosin 54 mg dosed twice 54 mcL 54 fraction LVEF 54 aged ≥ 54 3mg 54 decompensation Child Pugh 54 recurrent genital herpes 54 irbesartan 54 SGRQ 54 diopters 54 nicardipine 54 increaseof 54 -5 -6 54 bronchioloalveolar carcinoma 54 CIN2 + 54 FT Units subscribed 54 pimecrolimus cream 54 HBV DNA levels 54 serum phosphorus levels 54 Posaconazole 54 hepatitis C genotype 54 myelodysplastic myeloproliferative diseases 54 μSv 54 mmol liter 54 tetracaine 54 CTAP# Capsules 54 % CI #.#-#.# [001] 54 treatment emergent AEs 54 CMV infection 54 FOSRENOL ® 54 FOLFIRI alone 54 calcium Ca 54 kg -1 54 selective agonist 54 ACR# response 54 CrCl 54 mean baseline A1C 54 Repliform R revenues 54 dacarbazine 54 CIN3 + 54 PRADAXA #mg 54 pharmacologically active isomer 54 Copegus ribavirin 54 ng ml 54 fluticasone propionate FP 54 SMARTREND WATCHING FOR PULLBACK 54 dosis 54 NNT = 54 active comparator 54 virologic breakthrough 54 fluticasone furoate 54 moderately emetogenic 54 Segment PTOI 54 Enq# Index